Diabetic ketoacidosis (DKA) is widely recognized as an acute and severe complication primarily associated with type 1 diabetes (T1DM). However, the occurrence of DKA in individuals diagnosed with type 2 diabetes (T2DM) should not be underestimated. While it may be less common for adults with T2DM to experience DKA, metrics from health organizations, including the
Diabetes
Gvoke is a notable medication primarily indicated for the acute treatment of severe hypoglycemia. This drug is particularly relevant for individuals managing diabetes, as it directly addresses episodes of dangerously low blood sugar. The active ingredient, glucagon, plays a crucial role in quickly raising blood sugar levels when administered. However, when it comes to its